Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine

Franklin L. Nobrega, Ana Rita Costa, José F. Santos, Melvin F. Siliakus, Jan W.M. Van Lent, Servé W.M. Kengen, Joana Azeredo*, Leon D. Kluskens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

66 Citations (Scopus)


Orally administered phages to control zoonotic pathogens face important challenges, mainly related to the hostile conditions found in the gastrointestinal tract (GIT). These include temperature, salinity and primarily pH, which is exceptionally low in certain compartments. Phage survival under these conditions can be jeopardized and undermine treatment. Strategies like encapsulation have been attempted with relative success, but are typically complex and require several optimization steps. Here we report a simple and efficient alternative, consisting in the genetic engineering of phages to display lipids on their surfaces. Escherichia coli phage T7 was used as a model and the E. coli PhoE signal peptide was genetically fused to its major capsid protein (10 A), enabling phospholipid attachment to the phage capsid. The presence of phospholipids on the mutant phages was confirmed by High Performance Thin Layer Chromatography, Dynamic Light Scattering and phospholipase assays. The stability of phages was analysed in simulated GIT conditions, demonstrating improved stability of the mutant phages with survival rates 102-107 pfu.mL-1 higher than wild-type phages. Our work demonstrates that phage engineering can be a good strategy to improve phage tolerance to GIT conditions, having promising application for oral administration in veterinary medicine.
Original languageEnglish
Article number39235
JournalScientific Reports
Publication statusPublished - 2016


Dive into the research topics of 'Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine'. Together they form a unique fingerprint.

Cite this